What Are the Top Mid-Cap Growth Stocks to Invest In?

Mid-cap growth stocks are a popular choice for investors looking to diversify their portfolios and maximizereturns. These stocks are typically issued by companies with a market capitalization between $2 billion and $10 billion, and are known for their potential to outperform both large cap and small cap stocks in terms of growth and returns.

In this article, we will take a closer look at some of the top mid-cap growth stocks to invest in, based on their growth potential, financial performance, and market trends.

1. Zoom Video Communications Inc. (ZM)

Zoom has become a household name in recent years thanks to the global pandemic and remote work boom. The company offers a cloud-based video conferencing platform that has become essential for businesses and individuals alike. Zoom's revenue grew by over 350% in 2020 and is expected to continue growing in the coming years as remote work becomes more normalized.

2. DocuSign Inc. (DOCU)

DocuSign is another technology company that has seen significant growth in recent years. The company offers an electronic signature and document management platform that has become increasingly popular among businesses and individuals looking to streamline their workflows. DocuSign's revenue grew by over 50% in 2020 and is expected to continue growing as more businesses adopt digital solutions.

3. Square Inc. (SQ)

Square is a financial technology company that offers a range of services including payment processing, small business loans, and cryptocurrency trading. The company's revenue grew by over 140% in 2020 and is expected to continue growing as more businesses turn to digital payment solutions.

4. Roku Inc. (ROKU)

Roku is a streaming platform that offers a range of content including movies, TV shows, and live sports. The company's revenue grew by over 50% in 2020 and is expected to continue growing as more consumers cut the cord and turn to streaming services.

5. Moderna Inc. (MRNA)

Moderna is a biotechnology company that specializes in mRNA therapeutics and vaccines. The company's revenue grew by over 400% in 2020 thanks to the success of its COVID-19 vaccine. While the vaccine may not be a long-term revenue driver, Moderna's expertise in mRNA technology could lead to new breakthroughs in the coming years.

Investing in mid-cap growth stocks can be a lucrative strategy for investors looking to maximize returns. However, it's important to remember that these stocks can be volatile and carry a higher degree of risk than more established large-cap stocks. As with any investment strategy, it's important to do your research, diversify your portfolio, and consult with a financial advisor before making any investment decisions.